Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Sweden
  4. Nasdaq Stockholm
  5. Biovica International AB (publ)
  6. News
  7. Summary
    BIOVIC B   SE0008613731

BIOVICA INTERNATIONAL AB (PUBL)

(BIOVIC B)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Biovica International AB Publ Reports Earnings Results for the Fourth Quarter Ended April 30, 2021

06/17/2021 | 02:00am EDT

Biovica International AB publ announced earnings results for the fourth quarter ended April 30, 2021. For the fourth quarter, the company announced total revenue was SEK 1.141 million compared to SEK 1.834 million a year ago. Operating loss was SEK 12.169 million compared to SEK 10.296 million a year ago. Net loss was SEK 11.992 million compared to SEK 10.777 million a year ago. For the full year, total revenue was SEK 8.878 million compared to SEK 9.921 million a year ago. Operating loss was SEK 40.181 million compared to SEK 29.816 million a year ago. Net loss was SEK 39.482 million compared to SEK 30.318 million a year ago.


ę S&P Capital IQ 2021
All news about BIOVICA INTERNATIONAL AB (PUBL)
09/15BIOVICA INTERNATIONAL : DiviTum«TKa results from SWOG study published in Clinica..
AQ
09/15Biovica Announces DiviTum«TKa results from SWOG study published in Clinical C..
CI
09/14BIOVICA INTERNATIONAL : Promising DiviTumTKa results from BioItaLEE study presen..
AQ
09/13BIOVICA INTERNATIONA : Biovica International
AQ
09/13BIOVICA INTERNATIONAL : provides update on FDA application process
AQ
09/13Biovica International AB Provides Update on FDA Application Process
CI
08/31BIOVICA INTERNATIONAL : Announcement from Biovica International's annual general..
AQ
08/31BIOVICA INTERNATIONAL : DiviTum«TKa approaching FDA approval
AQ
08/27BIOVICA INTERNATIONAL : CEO's presentation ahead of the 2021 Annual General Meet..
AQ
08/10BIOVICA INTERNATIONAL : strengthens management team
AQ
More news
Financials
Sales 2022 48,6 M 5,59 M 5,59 M
Net income 2022 -32,6 M -3,74 M -3,74 M
Net cash 2022 252 M 29,0 M 29,0 M
P/E ratio 2022 -53,5x
Yield 2022 -
Capitalization 1 535 M 177 M 176 M
EV / Sales 2022 26,4x
EV / Sales 2023 8,46x
Nbr of Employees 20
Free-Float 41,9%
Chart BIOVICA INTERNATIONAL AB (PUBL)
Duration : Period :
Biovica International AB (publ) Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 1
Last Close Price 54,00 SEK
Average target price 103,00 SEK
Spread / Average Target 90,7%
EPS Revisions
Managers and Directors
Anders Rylander Chief Executive Officer & Director
Cecilia Driving CFO, Head-Human Resource, IR & EVP
Lars Erik Holmqvist Chairman
Mattias Bergqvist Director-Clinical Development
Otti Bengtsson Gref Director-Research & Development
Sector and Competitors